Abstract: The present invention relates to methods for consistently designating appropriate treatment protocols for patients, particularly protocols involving wounds or wound prevention. Specifically, the invention relates to methods wherein a patient condition such as a wound is assessed against defined scales for classifying and grading, which assessment is used in a visual decision tree device to identify one or more components of a treatment protocol.
Abstract: An apparatus is adapted to centrifuge a container for separating a component, such as fibrin monomer, from blood or plasma. The container includes a cylindrical member, and a piston displaceable therein and a tubular piston rod, which extends through a top wall of the cylindrical member. The piston divides the cylindrical member into a first chamber positioned above the piston between the piston and the top wall, and a second chamber positioned below the piston. The apparatus includes a supporting turntable which releasably retains the cylindrical member. The supporting turntable is connected to a first activator for rotating the supporting turntable with the container about the central axis thereof. The apparatus also includes a rotatably journalled piston activating mechanism adapted to activate the piston by a second activator.
Abstract: An iodine preparation composition suitable for use on wounds comprising an iodide source, an oxidant and a buffer characterized in that the iodide is held separately from the oxidant until the point of use, and that the buffer is capable of maintaining the pH of the composition at between pH 45 and pH 6 so that iodine is generated at a physiologically acceptable dose rate.
Type:
Grant
Filed:
March 13, 2000
Date of Patent:
March 21, 2006
Inventors:
Dave Parsons, Elizabeth Jacques, Philip Bowler
Abstract: A bandaging system for use in the treatment of a patient with a venous leg ulcer comprising as an inner layer in the system a highly absorbent bandage which bandage comprises at least 5% by weight of a highly absorbent fiber and as a further layer in the system an elastic bandage.
Abstract: A method and a device for separating a component, such as fibrin I from blood, by centrifugation. The method involves feeding of blood admixed an anticlotter to a first annular chamber in a device, where the annular chamber is defined by a cylindrical outer wall and a cylindrical inner wall, both walls extending coaxially about a common axis, as well as by a top wall and a bottom wall, where the top wall or the bottom wall is formed by a piston body displaceable within the first chamber. The method involves furthermore a centrifugation of the device about the said common axis followed by a resulting liquid fraction being transferred while influenced by the piston body to a second chamber defined by an outer cylindrical wall, which extends coaxially with said common axis.
Abstract: A thin film device for medical applications such as a wound dressing including an occlusive layer having an edge portion about at least a portion of the thin film device and a non-continuous, hydrocolloid-containing polymeric support layer overlying the edge portion of the occlusive layer.
Abstract: The present invention provides methods and devices for maintaining the integrity of blood products throughout preparation, processing and application to a patient or desired site. Coding methods are incorporated onto or into processing and delivery containers which coding methods contain information identifying the donor and/or recipient. Additionally or alternatively the coding methods may contain information pertaining to a specific preparation or application process to be carried out. Blood product processors and blood product applicators include decoding methods to ensure the blood product is administered to the appropriate recipient and further that it has been prepared and applied according to desired processes.
Type:
Grant
Filed:
July 24, 1998
Date of Patent:
January 25, 2005
Assignee:
Bristol-Myers Squibb Company
Inventors:
Raymond A. Carr, Michael J. Amery, Niels Erik Holm
Abstract: A multi layered wound dressing which comprises an adhesive layer, an absorbent layer overlying said adhesive layer on the surface furthest from the wound, and a moisture transmitting cover layer overlying the absorbent layer, the dressing having a total thickness of less than 1.5 mm.
Type:
Grant
Filed:
July 12, 2001
Date of Patent:
September 21, 2004
Assignee:
Bristol-Myers Squibb Company
Inventors:
Bryan Griffiths, David C. Pritchard, Elizabeth Jacques, Steven M. Bishop, Michael J. Lydon
Abstract: A bandaging system for-use in the treatment of a patient with a venous leg ulcer comprising as an inner layer in the system a highly absorbent bandage which bandage comprises at least 5% by weight of a highly absorbent fibre and as a further layer in the system an elastic bandage.
Abstract: Methods of enhancing the photostabilizing of silver in medical materials are described. More particularly, the methods increase the photostabilization of silver in certain materials comprising hydrophilic, amphoteric and anionic polymers by subjecting the polymers to solutions containing an organic solvent and silver, during or after which one or more agents are added which facilitate the photostablization of the material.
Type:
Grant
Filed:
November 29, 2001
Date of Patent:
December 30, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
David Parsons, Elizabeth Jacques, Philip Bowler
Abstract: Disclosed is an adhesive for gluing of biological tissue, in particular human body tissue. The adhesive contains fibrinogen, a substance capable of supplying calcium ions, blood-coagulating factor XIIIa and, as a fibrinogen-splitting substance, a snake-venom enzyme.
Type:
Grant
Filed:
May 17, 1996
Date of Patent:
September 2, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
Birger Blombäck, Birgit Hessel, Per Olsson, Lennart Strömberg, Jesper Swedenborg, Kurt Stocker
Abstract: A novel device and method for applying two or more liquid components, for example fibrin sealant-forming components, comprises sources of the components fliud communication with, but remote from, an applicator for delivering the components to a desired site. Preferably, the user of such a device and method can actuate the application of the components by providing a signal to a controller which dispenses components from their sources to, and out of, the applicator. Greater ease, accuracy and control are realized by the user since the sources of components and controller are remote from the applicator and therefore not manually held by the user.
Type:
Grant
Filed:
December 6, 1996
Date of Patent:
September 2, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
Niels Erik Holm, Allan Garbasch, John E. Fairbrother, Frank Castellana
Abstract: In accordance with the present invention it has been found that a fibrin polymer film formed by applying materials most closely resembling the natural clotting materials to a surgical adhesion formation. Preferred embodiments involve application of a fibrin monomer under polymerizing conditions to the surgical wound site. Unexpectedly, in addition to this improved prevention of adhesions, the more chemically-natural clots, especially the fibrin-monomer based fibrin polymer, also functions as a fibrin sealant, i.e., has adherence, provides hemostasis and promotes wound healing while also functioning as a barrier. In preferred embodiments the novel methods of this invention conveniently use one or more plasma proteins derived from the patient's own blood as to be autologous. Further, the sealant material is preferably substantially free of any added or exogenous enzymes, e.g., thrombin, etc., which catalyze the cleavage of fibrinopeptides A and/or B from fibrinogen.
Type:
Grant
Filed:
June 1, 2000
Date of Patent:
September 2, 2003
Assignee:
Bristol-Myers Squibb Company
Inventors:
Michael J. Amery, Paul Sibbons, Stuart Burnett, Sally-Anne Rickets, Peter A. D. Edwardson, Jonathan Hughes, Derek A. Hollingsbee, Stewart A. Cederholm-Williams, Horace R. Trumbull, Herman Eugene Griffin
Abstract: Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The composition may be in sprayable form or dispersed in an aqueous solution. Methods of making and using the compositions are also described.